MIAMI, May 01, 2018 -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, updates shareholders that it is no longer on the Regulation SHO watch list with OTCMarkets.
The Company recently began taking action to alleviate pressure caused by naked short positions in the Company’s stock. The Company contacted a number of broker/dealers, clearing firms, and reached out to FINRA’s Division of Market Regulation about the problem naked shorting is causing in the market for the Company’s securities. Management believes this effort of raising awareness within compliance offices has led to a significant decrease in naked short positions in the market, which has resulted in the removal of Progressive Care (OTCQB:RXMD) from the OTCMarkets Regulation SHO watch list for significant fails to deliver. The Company intends to continue contacting broker/dealers and clearing firms to ensure that they are complying with all regulations.
“We are pleased that our efforts have had a positive impact on the stability of the market for our stock,” stated S. Parikh Mars, CEO. "Our shareholders especially have done a tremendous job of contacting their firms to prevent their shares from being borrowed for short positions. We cannot prevent all instances of naked shorts, but we can apply pressure and raise awareness with broker/dealers and clearing firms to be vigilant in their compliance protocols in this regard. We will continue to monitor the situation and take action when necessary now and into the future.”
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected] www.progressivecareus.com www.pharmcopharmacy.com


Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 



